NTSHMDA: Prediction of Human Microbe-Disease Association Based on Random Walk by Integrating Network Topological Similarity

Accumulating clinic evidences have demonstrated that the microbes residing in human bodies play a significantly important role in the formation, development, and progression of various complex human diseases. Identifying latent related microbes for disease could provide insight into human disease mechanisms and promote disease prevention, diagnosis, and treatment. In this paper, we first construct a heterogeneous network by connecting the disease similarity network and the microbe similarity network through known microbe-disease association network, and then develop a novel computational model to predict human microbe-disease associations based on random walk by integrating network topological similarity (NTSHMDA). Specifically, each microbe-disease association pair is regarded as a distinct relationship level and, thus, assigned different weights based on network topological similarity. The experimental results show that NTSHMDA outperforms some state-of-the-art methods with average AUCs of 0.9070, 0.8896 <inline-formula><tex-math notation="LaTeX">$\pm$</tex-math><alternatives><mml:math><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="luo-ieq1-2883041.gif"/></alternatives></inline-formula> 0.0038 in the frameworks of Leave-one-out cross validation and 5-fold cross validation, respectively. In case studies, 9, 18, 38 and 9, 18, 45 out of top-10, 20, 50 candidate microbes are verified by recently published literatures for asthma and inflammatory bowel disease, respectively. In conclusion, NTSHMDA has potential ability to identify novel disease-microbe associations and can also provide valuable information for drug discovery and biological researches.

[1]  Duc-Hau Le,et al.  Random walks on mutual microRNA-target gene interaction network improve the prediction of disease-associated microRNAs , 2017, BMC Bioinformatics.

[2]  R. Knight,et al.  Meta‐analyses of human gut microbes associated with obesity and IBD , 2014, FEBS letters.

[3]  Hélène Falentin,et al.  Combining selected immunomodulatory Propionibacterium freudenreichii and Lactobacillus delbrueckii strains: Reverse engineering development of an anti-inflammatory cheese. , 2016, Molecular nutrition & food research.

[4]  Jennifer C. Drew,et al.  Toward defining the autoimmune microbiome for type 1 diabetes , 2011, The ISME Journal.

[5]  Xing Chen,et al.  Drug-target interaction prediction by random walk on the heterogeneous network. , 2012, Molecular bioSystems.

[6]  W E Moore,et al.  Intestinal floras of populations that have a high risk of colon cancer , 1995, Applied and environmental microbiology.

[7]  De-Shuang Huang,et al.  Novel human microbe-disease association prediction using network consistency projection , 2017, BMC Bioinformatics.

[8]  Xiangxiang Zeng,et al.  Prediction of potential disease-associated microRNAs using structural perturbation method , 2017, bioRxiv.

[9]  Mohammad Reza Zali,et al.  Prevalence of superantigenic Staphylococcus aureus and toxigenic Clostridium difficile in patients with IBD , 2012 .

[10]  Xiangxiang Zeng,et al.  Inferring MicroRNA-Disease Associations by Random Walk on a Heterogeneous Network with Multiple Data Sources , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[11]  Duc-Hau Le,et al.  Neighbor-favoring weight reinforcement to improve random walk-based disease gene prioritization , 2013, Comput. Biol. Chem..

[12]  S. Taylor-Robinson,et al.  The promise of metabolic phenotyping in gastroenterology and hepatology , 2015, Nature Reviews Gastroenterology &Hepatology.

[13]  George Casella,et al.  Fecal Microbiota in Premature Infants Prior to Necrotizing Enterocolitis , 2011, PloS one.

[14]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.

[15]  Huanqing Feng,et al.  NTSMDA: prediction of miRNA-disease associations by integrating network topological similarity. , 2016, Molecular bioSystems.

[16]  F. Bäckhed,et al.  The gut microbiota — masters of host development and physiology , 2013, Nature Reviews Microbiology.

[17]  Xing Chen,et al.  Prediction of microbe–disease association from the integration of neighbor and graph with collaborative recommendation model , 2017, Journal of Translational Medicine.

[18]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Cheng Liang,et al.  A graph regularized non-negative matrix factorization method for identifying microRNA-disease associations , 2018, Bioinform..

[20]  Lei Wang,et al.  BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction , 2018, Bioinform..

[21]  Jong-Wook Shin,et al.  Lung Microbiome Analysis in Steroid-Naїve Asthma Patients by Using Whole Sputum , 2016, Tuberculosis and respiratory diseases.

[22]  Jingpu Zhang,et al.  A novel approach for predicting microbe-disease associations by bi-random walk on the heterogeneous network , 2017, PLoS ONE.

[23]  Shareef M Dabdoub,et al.  The subgingival microbiome of clinically healthy current and never smokers , 2014, The ISME Journal.

[24]  Marcus J. Claesson,et al.  Genome-scale analyses of health-promoting bacteria: probiogenomics , 2009, Nature Reviews Microbiology.

[25]  Wei Tang,et al.  Tumor origin detection with tissue‐specific miRNA and DNA methylation markers , 2018, Bioinform..

[26]  R. Knight,et al.  The Human Microbiome Project , 2007, Nature.

[27]  A. Sonnenberg,et al.  Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease , 2012, Alimentary pharmacology & therapeutics.

[28]  Fein Bt,et al.  Bronchial asthma caused by Pseudomonas aeruginosa diagnosed by bronchoscopic examination. , 1955 .

[29]  Xing Chen miREFRWR: a novel disease-related microRNA-environmental factor interactions prediction method. , 2016, Molecular bioSystems.

[30]  Jing Li,et al.  Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation. , 2017, Respiratory medicine.

[31]  Tülin Demir,et al.  Pneumonia due to Enterobacter cancerogenus infection , 2014, Folia Microbiologica.

[32]  Zhu-Hong You,et al.  PBHMDA: Path-Based Human Microbe-Disease Association Prediction , 2017, Front. Microbiol..

[33]  Zhu-Hong You,et al.  A novel approach based on KATZ measure to predict associations of human microbiota with non‐infectious diseases , 2016, Bioinform..

[34]  Zhen Shen,et al.  CMFHMDA: Collaborative Matrix Factorization for Human Microbe-Disease Association Prediction , 2017, ICIC.

[35]  J. Doré,et al.  Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.

[36]  M. Crowell,et al.  Human gut microbiota in obesity and after gastric bypass , 2009, Proceedings of the National Academy of Sciences.

[37]  Tim Urich,et al.  Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis , 2012, The ISME Journal.

[38]  B. Haas,et al.  A Catalog of Reference Genomes from the Human Microbiome , 2010, Science.

[39]  U. Ghoshal,et al.  Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: Possible role in renal stone formation , 2004, Journal of gastroenterology and hepatology.

[40]  Jing Zhang,et al.  Prediction of Novel Drugs for Hepatocellular Carcinoma Based on Multi-Source Random Walk , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[41]  C. Taube,et al.  The role of Helicobacter pylori infection in the development of allergic asthma , 2012, Expert review of respiratory medicine.

[42]  J. Clemente,et al.  Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans , 2011, Science.

[43]  George M Weinstock,et al.  The relationships between environmental bacterial exposure, airway bacterial colonization, and asthma , 2014, Current opinion in allergy and clinical immunology.

[44]  Emily R. Davenport,et al.  Seasonal Variation in Human Gut Microbiome Composition , 2014, PloS one.

[45]  Paul Wilmes,et al.  A microfluidics-based in vitro model of the gastrointestinal human–microbe interface , 2016, Nature Communications.

[46]  Peter Cimermancic,et al.  A Systematic Analysis of Biosynthetic Gene Clusters in the Human Microbiome Reveals a Common Family of Antibiotics , 2014, Cell.

[47]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[48]  Olli Simell,et al.  Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes , 2011, PloS one.

[49]  B. Finlay,et al.  Host–microbe interactions , 2007, Nature.

[50]  Xianjun Shen,et al.  Predicting disease-microbe association by random walking on the heterogeneous network , 2016, 2016 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[51]  Xiangxiang Zeng,et al.  Probability-based collaborative filtering model for predicting gene–disease associations , 2017, BMC Medical Genomics.

[52]  Martin J. Blaser,et al.  Substantial Alterations of the Cutaneous Bacterial Biota in Psoriatic Lesions , 2008, PloS one.

[53]  Lawrence A. David,et al.  Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.

[54]  Zexuan Zhu,et al.  LRLSHMDA: Laplacian Regularized Least Squares for Human Microbe–Disease Association prediction , 2017, Scientific Reports.